International Journal of Medical and Pharmaceutical Case Reports 2023-02-01T05:51:03+00:00 International Journal of Advances in Nephrology Research Open Journal Systems <p style="text-align: justify;"><strong>International Journal of Medical and Pharmaceutical Case Reports (IJMPCR) (ISSN: 2394-109X)</strong> aims to publish case reports in the areas of medical and pharmaceutical sciences. By not excluding papers based on novelty, this journal facilitates the research and wishes to publish papers as long as they are technically correct and scientifically motivated. The journal also encourages the submission of useful reports of negative results. This is a quality controlled, OPEN peer-reviewed, open-access INTERNATIONAL journal.</p> <p style="text-align: justify;">This is an open-access journal which means that all content is freely available without charge to the user or his/her institution. Users are allowed to read, download, copy, distribute, print, search, or link to the full texts of the articles, or use them for any other lawful purpose, without asking prior permission from the publisher or the author. This is in accordance with the BOAI definition of open access.</p> Scheimpflug Imaging of Late-onset Capsular Bag Distention Syndrome Treated with Nd: YAG Laser: A Case Report 2023-02-01T05:51:03+00:00 Andreas Katsimpris Maria Moleron Aristotelis Karamaounas Stylianos Kandarakis <p><strong>Aims: </strong>To report a case of very late-onset capsular bag distention syndrome (CBDS) 8 years after uncomplicated cataract surgery treated with Neodymium: Yag (Nd: Yag) laser posterior capsulotomy.</p> <p><strong>Presentation of the Case:</strong>&nbsp; A 76-year-old female patient without any systemic or ocular disorders, presented with progressive blurry vision in her right eye (RE) over the last 1 year. Best-corrected visual acuity (BCVA) was 6/9 in the right eye and 6/6 in the left eye. Manifest refraction revealed a 0.5 diopters myopic shift in her RE compared to her last ocular examination 2 years ago. Scheimpflug photograpgy and slit-lamp examination were utilized to make the diagnosis of CBDS, which was successfully treated with Nd: Yag laser posterior capsulotomy. At day 1 post-capsulotomy the BCVA of her RE improved to 6/6 with a 0.5 diopters hyperopic shift which was consistent with a 0.13 mm post-capsulotomy increase in the anterior chamber depth, as documented by the Scheimpflug images.</p> <p><strong>Discussion and Conclusion:</strong> Late-onset CBDS can manifest after a considerable time period following cataract surgery and Scheimpflug imaging can be a useful aid for a precise diagnosis and documentation of the treatment.</p> 2023-01-26T00:00:00+00:00 ##submission.copyrightStatement## A Rare Incidence of Ethambutol Induced Toxic Optic Neuropathy 2023-01-20T13:19:33+00:00 M. V. Mousigan L. Nissi V. Sreenivasan <p>Ethambutol induces toxic optic neuropathy (EON), which most typically presents as bilateral symmetrical loss of vision and, due to a lack of early detection and adequate treatment, often causes serious irreversible visual impairment. EON is time and dose dependent. In this case report, we will discuss a 59-year-old female patient who came in with complaints of visual impairment, inclusive of a colour vision defect (dyschromatopsia) and blurred vision (scotoma). Her past medication history includes use of first-line anti-tubercular therapy (ATT) with four drugs: Rifampicin, Isoniazid, Ethambutol, and Pyrazinamide. Pyrazinamide was taken for two months, and other medications (Rifampicin, Isoniazid, and Ethambutol) were taken for a period of seven months. From this case report, we will get a clear picture necessitating continuous monitoring for ocular toxicity.</p> 2023-01-02T00:00:00+00:00 ##submission.copyrightStatement##